Corporate
Description
  • Value proposition

    Transforming Lives, Every Day.

    Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs.

    Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.

    GL/NP/0116
    GL/NP/0095

    Community Guidelines: https://bit.ly/39x9gqy

    Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, and nephrology

Entity interactions BETA
Entity TypeTweets Articles
ISTUD Business School ISTUD Business School
Higher Education, edtech
Other

31 Dec 2024


Nature Portfolio Nature Portfolio
Book and Periodical Publishing
Other

21 Jan 2025


Festival de la Communication Santé Festival de la Communication Santé
Wellness and Fitness Services, healthtech
Other

4 Feb 2025


RARE à l'écoute 🎤🧬 1er Média d’Influence 100% maladies rares RARE à l'écoute 🎤🧬 1er Média d’Influence 100% maladies rares
healthtech
Other

5 Dec 2024


Entraide Scolaire Amicale Entraide Scolaire Amicale
edtech
Other

18 Nov 2024


Wirtschaftsforum Wirtschaftsforum
Media Production, consulting
Other

17 Nov 2024


Butler Scientifics Butler Scientifics
Biotechnology Research, it services, biotech, deeptech
Other

30 Sep 2024


Cariotipo Cariotipo
Public Relations and Communications Services, healthtech
Other

5 Nov 2024


SeqOne SeqOne
Biotechnology Research, healthtech, biotech, deeptech
Other

9 Oct 2024


icometrix icometrix
Hospitals and Health Care, healthtech, deeptech
Other

25 Sep 2024


Radars
Loading...